Company profile
Ticker
FTRE
Exchange
Employees
Location
Fiscal year end
Industry (SIC)
Former names
Silver Spinco Inc.
SEC CIK
Corporate docs
Subsidiaries
Fortrea Argentina S.A. • Fortrea Australia Pty Ltd • Fortrea Austria GmbH • Covance (Barbados) Holdings Ltd. • Covance (Barbados) Ltd. • Fortrea Belgium SRL • Chiltern Pesquisa Clinica Ltda. • Fortrea Brazil Limitada • Fortrea Development Limited • Theorem Research ...
IRS number
922796441
FTRE stock data
Latest filings (excl ownership)
8-K
Departure of Directors or Certain Officers
1 Apr 24
ARS
2023 FY
Annual report to shareholders
28 Mar 24
DEFA14A
Additional proxy soliciting materials
28 Mar 24
DEF 14A
Definitive proxy
28 Mar 24
10-K
2023 FY
Annual report
13 Mar 24
8-K
Fortrea Reports Fourth Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance
11 Mar 24
8-K
Fortrea Previews J.P. Morgan Healthcare Conference Updates
8 Jan 24
8-K
Regulation FD Disclosure
29 Nov 23
8-K
Other Events
21 Nov 23
10-Q
2023 Q3
Quarterly report
13 Nov 23
Latest ownership filings
4
Betty D Larson
1 Apr 24
4
Jill G. Mcconnell
15 Mar 24
4
Mark A. Morais
15 Mar 24
4
James S. Hanson
15 Mar 24
4
Amanda M. Warren
15 Mar 24
4
Jill G. Mcconnell
6 Mar 24
4
Mark A. Morais
6 Mar 24
SC 13D/A
Starboard Value LP
26 Feb 24
SC 13G
Sessa Capital (Master), L.P.
14 Feb 24
4
Jill G. Mcconnell
13 Feb 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | |||
---|---|---|---|---|---|---|
Cash on hand (at last report) | 107.50 mm | 107.50 mm | 107.50 mm | |||
Cash burn (monthly) | 2.27 mm | 5.97 mm | (no burn) | |||
Cash used (since last report) | 15.68 mm | 41.27 mm | n/a | |||
Cash remaining | 91.82 mm | 66.23 mm | n/a | |||
Runway (months of cash) | 40.5 | 11.1 | n/a |
Institutional ownership, Q4 2023
75.9% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 335 |
Opened positions | 64 |
Closed positions | 126 |
Increased positions | 62 |
Reduced positions | 140 |
13F shares | Current |
---|---|
Total value | 2.01 tn |
Total shares | 67.86 mm |
Total puts | 40.10 k |
Total calls | 11.40 k |
Total put/call ratio | 3.5 |
Largest owners | Shares | Value |
---|---|---|
Royal London Asset Management | 16.50 mm | $575.85 bn |
Vanguard | 9.95 mm | $347.11 bn |
Starboard Value | 7.77 mm | $217.54 mm |
Boston Partners | 3.82 mm | $132.74 bn |
STT State Street | 2.88 mm | $100.44 bn |
Beck Mack & Oliver | 2.13 mm | $74.33 bn |
Gates Capital Management | 1.94 mm | $67.86 bn |
MS Morgan Stanley | 1.87 mm | $65.41 bn |
Brandes Investment Partners | 1.69 mm | $59.06 bn |
Coliseum Capital Management | 1.48 mm | $51.73 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
30 Mar 24 | Betty D Larson | Common Stock | Option exercise | Acquire M | No | No | 0 | 6,354 | 0.00 | 6,354 |
30 Mar 24 | Betty D Larson | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 6,354 | 0.00 | 0 |
13 Mar 24 | James S. Hanson | RSU Common Stock | Grant | Acquire A | No | No | 0 | 8,996 | 0.00 | 32,120 |
13 Mar 24 | Jill G. Mcconnell | RSU Common Stock | Grant | Acquire A | No | No | 0 | 12,851 | 0.00 | 86,750 |
13 Mar 24 | Mark A. Morais | RSU Common Stock | Grant | Acquire A | No | No | 0 | 12,851 | 0.00 | 87,505 |
13 Mar 24 | Amanda M. Warren | RSU Common Stock | Grant | Acquire A | No | No | 0 | 3,856 | 0.00 | 18,825 |
News
Where Fortrea Holdings Stands With Analysts
22 Mar 24
Baird Initiates Coverage On Fortrea Holdings with Neutral Rating, Announces Price Target of $43
22 Mar 24
B of A Securities Maintains Underperform on Fortrea Holdings, Raises Price Target to $33
12 Mar 24
12 Health Care Stocks Moving In Monday's Pre-Market Session
11 Mar 24
Fortrea Holdings Q4 Adjusted EPS $0.19 Misses $0.24 Estimate, Sales $775.40M Miss $776.06M Estimate
11 Mar 24
Press releases
Fortrea Announces Date for First Quarter 2024 Financial Results and Conference Call
11 Apr 24
Fortrea Reports Fourth Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance
11 Mar 24
Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
11 Mar 24